Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12643420.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with prolonged severe cardiogenic shock requiring implantation of a biventricular assist device may develop diffuse bleeding due to alteration of hepatic and renal function and subsequent coagulopathy. Bleeding control in these patients may be difficult despite massive use of blood products. We report on the successful use of recombinant activated factor VII for control of massive bleeding after implantation of a biventricular assist device in a patient with prolonged severe cardiogenic shock.
Medical subject headings
- Factor VII
- Heart-Assist Devices
- Postoperative Hemorrhage
- Recombinant Proteins